Navigate to
-
Pharmacy Practice News, originally published by Specialty Pharmacy Continuum
PA Sub-Categories: GLP-1 Prime Article: In the News -
BioSpace: As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health outcomes—evidenced by successful studies in therapeutic areas like...
PA Sub-Categories: GLP-1 Prime Article: In the News -
Manufacturer: Ferring / Seikagaku Proposed indications Radicular leg pain associated with lumbar disc herniation (LDH) Clinical overview Mechanism of action Condoliase, also known as chondroitin...
-
Editor's message Editorial team Cell therapy= Transplantation of healthy cells to replace or repair damaged ones *Orphan drug status PDUFA= Prescription Drug User Fee Act IV= intravenous...
-
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...
PA Sub-Categories: GLP-1 Products Specialty drugs Technology Prime Article: Perspectives -
Manufacturer: Abeona Proposed indications Recessive dystrophic epidermolysis bullosa (RDEB) Clinical overview Mechanism of action Prademagene zamikeracel (pz-cel) is an autologous, collagen type...
-
Prime to present seven studies and receive the 2024 JMCP Award for Excellence
PA Sub-Categories: GLP-1 Technology Prime Article: Press Releases -
Cover image for Quarterly Drug Pipeline: January 2025 Updates on promising therapies in development, focusing on drugs nearing FDA approval Prime Therapeutics /quarterly-drug-pipeline-january-2025...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -
cover image for Quarterly Drug Pipeline: October 2024 Quarterly Drug Pipeline: October 2024 Prime Therapeutics /quarterly-drug-pipeline-october-2024 Prime Therapeutics’ Quarterly Drug Pipeline...
Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline -